ACADIA Pharmaceuticals Inc. vs Aspen Aerogels Inc — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.52 (market cap $5.07B), while Aspen Aerogels Inc trades at $6.15 (market cap $509.55M). The key difference: ACADIA Pharmaceuticals Inc. is far larger — about 9.9× Aspen Aerogels Inc's market cap, and ACADIA Pharmaceuticals Inc. is trading nearer its 52-week high, Aspen Aerogels Inc nearer its low. Which is the better fit depends on your goals.
| ACAD | ASPN | |
|---|---|---|
Market Cap | $5.07B | $509.55M |
Sector | Health | Technology |
52-Week High | $29.41 | $8.82 |
52-Week Low | $20.06 | $2.57 |
Enterprise Value | $4.19B | $482.96M |
Trailing returns across standard periods
Latest headlines on both assets
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →Aspen Aerogels is an aerogel technology company that designs high-performance insulation. Its products are used in energy infrastructure and electric vehicles to provide thermal management and fire protection.
Read more on ASPN →